Business Standard
Tuesday, May 29, 2012
Sponsored by  
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
||||Economy & Policy||||| 
 Section Home | News Now | Today's Paper | Features & Analysis | Politics & Public Affairs | Q&A | Columnists | BS Says
Home > Economy & Policy Live Markets | Commodities
 

Internet flooded with fake remedies for swine flu
Press Trust of India / New Delhi May 14, 2009, 10:23 IST

With swine flu triggering a worldwide scare, a number of websites have come up with fake herbal remedies, protection guides and advertisements espousing a magic cure.      

According to McAfee security experts, Internet domain registrations mentioning the word "swine" have gone up, indicating a rise in malicious sites that take advantage of the scare.      

A new site offers a dodgy "Swine Flu Prevention Guide" for $19.95, Mcafee says.    

While another company claims H1N1 cure that works in 12 hours, the report says.      

"This compound does not treat the flu symptoms but instead kills the virus in a few hours. It has no known side effects and no adverse long term effects," the advertisement claims.      

A new promotion on the web also asserts that swine flu can be eradicated by using colloidal silver, a mixture that includes very fine silver particles and claims, "Here are 7 important steps you should consider taking right now in order to protect yourself and your family."      

US Food and Drug Association in 1999 had banned claims of therapeutic value for over-the-counter colloidal silver products as studies had pointed out that it could cause seizures and kidney damage.

Numerous websites are also offering homeopathic and ayurvedic treatment to the dreaded disease.      

"Allopathic medicine has no "cure" for flu. Rather, allopathy only attempts to "control" the disease. However, Ayurveda treats flu by removing its root cause and giving permanent relief," claims a website naming cinnamon, basil leaves, cloves as useful in overcoming swine flu.      

The US FDA and the Federal Trade Commission had also recently alerted the public to be wary of Internet sites and other promotions for products that claim to prevent the H1N1 influenza virus.      

"Products that are offered for sale to the public with claims to diagnose, prevent, mitigate, treat, or cure infections caused by the H1N1 influenza virus that have not been proven to be safe and effective for these uses must be carefully evaluated," the statement said.      

"Many of these deceptive products are being sold over the Internet via illegitimate web sites. The operators of these web sites take advantage of the public's concerns about H1N1 influenza and their desire to protect themselves and their families," it said.     

The two antiviral drugs approved by the FDA for treatment and prophylaxis of the 2009 H1N1 influenza virus are Tamiflu (oseltamivir phosphate) and Relenza (zanamivir)," it added.

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Markets end on a strong note
- Nabard FY14 operating surplus soars 28% to Rs 1,635 cr
- RBI eases banks' term deposit restrictions
- NMDC Q4 net down 21.74% to Rs 1,642.28 cr
- Balrampur Chini Q4 profit up by 15%
  Read Business news in 
- Journey on, We are by Your Side. Click here to know more
- Help a Child Achieve her. Click to know more
- Benefits Upto Rs. 2.36 Lakhs on the Fully Loaded TJet Petrol.
- The Best Seller is Also the No. 1 in Mileage. Click here
- Watch The Film Here. Click here to know more..
- Leader in Passenger Car & Automobile Tyres. Click here
- 1 billion in saving for Unilever without any tangles.
- Learn How One City is Running on FOOD SCRAPS.
- One Partnership Endless Possibilities. Click here to know more
- Helping doctors detect diseases earlier, saving costs & extending lives.
- 36 Lakhs can get you a pool of Luxuries. Click here
- Which is the best plan for your daughter
- Check out the TRUE COLOURS of your Stocks, Now for FREE!
- One of the leading business schools in the world.Know More
Sorry, comments to this story are closed
Latest Messages
Table for Two
  Now available at Special price
  Rs.280/- Only

  Buy Now
BS POLL
UPA 2 has completed three years. How do you rate its performance?  Read the story
  Good
  Average
  Bad
Submit
Most Popular
Read
E-Mailed
Commented
   
- Rupee strengthens to 55.05/dollar
- Why Indian private equity is at the crossroads
 
 More  
New Ipad Application
 Business Standard's all new IPad  App
 Click here to download for free
  Hot Searches  
 
Apalya |  Air India |  GAAR |  Agni  |  Solar eclipse |  Satyamev Jayate |  SRK |  Aamir Khan |  IPL |  Ertiga |  Sarfaesi Act |  Vodafone |  JP Morgan |  Transfer pricing |  Rupee |  Kingfisher Airlines |  Silver |  Provident Fund |  income tax refund |  iPhone |  Reliance Industries |  SEBI |  BSNL |  BSE |  NSE |  Mukesh Ambani |  Anil Ambani |  Infosys |  Pranab Mukherjee |  Sonia Gandhi |  Rahul Gandhi |  New Pension Scheme |  Reliance |  RBI |  GDP |  Gold |  Ratan Tata |  ICICI |  B-School |  Sensex |  Tax calculator |  Home Loan |  Personal Finance |  inflation |  oil prices |  Barack Obama |   
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World | General News
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us